Source:http://linkedlifedata.com/resource/pubmed/id/17478008
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-7-16
|
pubmed:abstractText |
Target volume delineation of lung cancer is well known to be prone to large inter-observer variability. The advent of PET/CT devices, with co-registered functional and anatomical data, has opened new exciting possibilities for target volume definition in radiation oncology. PET/CT imaging is rapidly being embraced by the radiation oncology community as a tool to improve the accuracy of target volume delineation for treatment optimization in NSCLC. Several studies have dealt with the feasibility of incorporating FDG-PET information into contour delineation with the aim to improve overall accuracy and to reduce inter-observer variation. A significant impact of PET-derived contours on treatment planning has been shown in 30-60% of the plans with respect to the CT-only target volume. The most prominent changes in the gross tumour volume (GTV) have been reported in cases with atelectasis and following the incorporation of PET-positive nodes in otherwise CT-insignificant nodal areas. Although inter-observer variability is still present following target volume delineation with PET/CT, it is greatly reduced compared to conventional CT-only contouring. PET/CT may also provide improved therapeutic ratio compared to conventional CT planning. Increased target coverage and often reduced target volumes may potentially result in PET/CT-based planning to yield better tumour control probability through dose escalation, while still complying with dose/volume constrains for normal tissues. Despite these exciting results, more clinical studies need to be performed to better define the role of combined PET/CT in treatment planning for NSCLC.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0169-5002
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
125-34
|
pubmed:meshHeading |
pubmed-meshheading:17478008-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17478008-Dose-Response Relationship, Radiation,
pubmed-meshheading:17478008-Fluorodeoxyglucose F18,
pubmed-meshheading:17478008-Humans,
pubmed-meshheading:17478008-Lung Neoplasms,
pubmed-meshheading:17478008-Observer Variation,
pubmed-meshheading:17478008-Positron-Emission Tomography,
pubmed-meshheading:17478008-Radiopharmaceuticals,
pubmed-meshheading:17478008-Radiotherapy, Conformal,
pubmed-meshheading:17478008-Radiotherapy Dosage,
pubmed-meshheading:17478008-Tomography, X-Ray Computed,
pubmed-meshheading:17478008-Tumor Burden
|
pubmed:year |
2007
|
pubmed:articleTitle |
Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).
|
pubmed:affiliation |
Division of Radiation Oncology, University of Magna Graecia, Viale Europa, Germaneto, Catanzaro 88100, Italy. grecoc@mskcc.org
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Review
|